These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
541 related articles for article (PubMed ID: 24335532)
1. Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. Ferrer I; López-González I; Carmona M; Arregui L; Dalfó E; Torrejón-Escribano B; Diehl R; Kovacs GG J Neuropathol Exp Neurol; 2014 Jan; 73(1):81-97. PubMed ID: 24335532 [TBL] [Abstract][Full Text] [Related]
2. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy. Ferrer I; Andrés-Benito P; Zelaya MV; Aguirre MEE; Carmona M; Ausín K; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E; Del Rio JA Acta Neuropathol; 2020 Apr; 139(4):735-771. PubMed ID: 31907603 [TBL] [Abstract][Full Text] [Related]
3. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. Ferrer I; Blanco R; Carmona M; Puig B J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404 [TBL] [Abstract][Full Text] [Related]
4. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387 [TBL] [Abstract][Full Text] [Related]
5. αB-crystallin and HSP27 in glial cells in tauopathies. López-González I; Carmona M; Arregui L; Kovacs GG; Ferrer I Neuropathology; 2014 Dec; 34(6):517-26. PubMed ID: 24985029 [TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
8. Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies. Ferrer I; Aguiló García M; Carmona M; Andrés-Benito P; Torrejón-Escribano B; Garcia-Esparcia P; Del Rio JA Front Aging Neurosci; 2019; 11():112. PubMed ID: 31191295 [No Abstract] [Full Text] [Related]
9. Tau exhibits unique seeding properties in globular glial tauopathy. Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985 [TBL] [Abstract][Full Text] [Related]
11. [Neuropathology of tauopathy]. Yoshida M Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931 [TBL] [Abstract][Full Text] [Related]
12. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity. Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439 [TBL] [Abstract][Full Text] [Related]
13. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies. Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398 [TBL] [Abstract][Full Text] [Related]
14. Atypical globular glial tauopathy with a combination of types I and II pathology. Kon T; Mori F; Arai A; Miki Y; Tanji K; Kurotaki H; Tomiyama M; Wakabayashi K Neuropathology; 2019 Apr; 39(2):127-134. PubMed ID: 30723950 [TBL] [Abstract][Full Text] [Related]
15. Relevance of host tau in tau seeding and spreading in tauopathies. Ferrer I; Zelaya MV; Aguiló García M; Carmona M; López-González I; Andrés-Benito P; Lidón L; Gavín R; Garcia-Esparcia P; Del Rio JA Brain Pathol; 2020 Mar; 30(2):298-318. PubMed ID: 31397930 [TBL] [Abstract][Full Text] [Related]
16. Dementia with Lewy bodies from the perspective of tauopathy. Iseki E; Togo T; Suzuki K; Katsuse O; Marui W; de Silva R; Lees A; Yamamoto T; Kosaka K Acta Neuropathol; 2003 Mar; 105(3):265-70. PubMed ID: 12557014 [TBL] [Abstract][Full Text] [Related]
17. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype. Mimuro M; Yoshida M; Miyao S; Harada T; Ishiguro K; Hashizume Y J Neurol Sci; 2010 Mar; 290(1-2):177-82. PubMed ID: 20022024 [TBL] [Abstract][Full Text] [Related]
18. The neuropathological spectrum of neurodegenerative tauopathies. Tolnay M; Probst A IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731 [TBL] [Abstract][Full Text] [Related]
19. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467 [TBL] [Abstract][Full Text] [Related]